Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Amide pentaacetyl geniposide derivative as well as preparation method and application thereof

A technology of pentaacetylgeniposide and geniposide, which is applied in the field of amide pentaacetylgeniposide derivatives and their preparation, can solve the problems of inability to be directly applied clinically and low activity, and improve the activity of kidney damage , reduce inflammatory response, and significantly inhibit activity

Active Publication Date: 2022-06-28
VEGETABLE RES INST OF SHANDONG ACADEMY OF AGRI SCI
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Geniposide has anti-inflammatory, uric acid-lowering, blood-sugar-lowering, and blood-pressure-lowering activities, but due to its low activity, it cannot be directly used clinically

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amide pentaacetyl geniposide derivative as well as preparation method and application thereof
  • Amide pentaacetyl geniposide derivative as well as preparation method and application thereof
  • Amide pentaacetyl geniposide derivative as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Example 1 Synthesis of Geniposide Lead Compound - Geniposide

[0058] (1) Synthesis of Geniposide (1a)

[0059]

[0060] Geniposide (100.0 mg, 0.257 mmol) and 10 mL of 4 % NaOH solution were added to the round-bottomed flask in turn, and the reaction was stirred under reflux at 65 °C, and the reaction was followed by TLC until the starting point disappeared (developing agent v / v: Dichloromethane / methanol=5 / 1). After the reaction is completed, use 1M hydrochloric acid to neutralize to pH=7, purify, and concentrate the obtained reaction solution to dryness under reduced pressure, pass through the column (eluent v / v: dichloromethane / methanol=8 / 1-1 / 1), 61.5 mg of white powder was obtained, mp. 250.9-251.6 °C, yield 91.3%, which was determined to be geniposide (1a) by NMR, HR-MS and other analysis. Spectrum such as Image 6 shown.

[0061] 1 H NMR (400 MHz, CD 3 OD) δ 7.19 (d, J = 11.5 Hz, 1H), 5.01 (dd, J =9.1, 5.4 Hz, 1H), 4.64 (dd, J = 12.4, 8.4 Hz, 1H)...

Embodiment 2

[0062] Example 2 Synthesis of Geniposide Derivative Pentaacetyl Geniposide (2a)

[0063] (1) Synthesis of pentaacetylgeniposide (2a)

[0064]

[0065] Geniposide derivative 1a (100.0 mg, 0.026 mmol) and 5 mL of triethylamine were added to the round-bottomed flask in turn, cooled in an ice-water bath, and 5 mL of acetic anhydride was slowly added dropwise with stirring. After the dropwise addition, the ice-water bath was removed. , the reaction was carried out at room temperature, and TLC was traced to the disappearance of the starting material point (developing solvent v / v: petroleum ether / ethyl acetate=1 / 1, 1 drop of formic acid). After the reaction, the reaction solution was washed with saturated NaHCO 3 The solution (20 mL) was neutralized to pH=7.0, washed with deionized water (20 mL × 3), the organic phases were combined, anhydrous Na 2 SO 4 Dry overnight and remove Na by suction filtration 2 SO 4 After distillation under reduced pressure, passed through the colum...

Embodiment 3 5

[0068] Example 3 Synthesis of pentaacetylgeniposide-1''-pyrrole amide (6a)

[0069] Pentaacetylgeniposide-1''-pyrroleamide (6a) structural formula:

[0070]

[0071] The synthesis method is as follows:

[0072] (1) Geniposide derivative 2a (200.0 mg, 0.34 mmol) DMF (3 mL), EDCI (78.0 mg, 0.41 mmol) in a stirred solution, HOBT (55.0 mg, 0.41 mmol) and DIPEA (0.2 mL) were added , 1.02 mmol), stirred at room temperature for 2 h;

[0073] (2) After stirring, 1-aminopyrrole (30.0 mg, 0.37 mmol) and DMAP (63.0 mg, 0.51 mmol) were added, and the stirring was continued overnight at room temperature;

[0074] (3) After the reaction, the solution used was added to ice water (30 mL) and extracted with dichloromethane (20 mL × 3). The combined organic solvent was washed with 1 M water diluted hydrochloric acid (20 mL × 3) and saturated brine (20 mL × 3). The organic phase is in anhydrous anhydrous Na 2 SO 4 It was dried overnight, distilled under reduced pressure, and purified by...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of preparation of novel compounds, and particularly relates to an amide pentaacetyl geniposide derivative as well as a preparation method and application thereof. The amide penta-acetyl geniposide derivative provided by the invention is prepared by the following steps: firstly, hydrolyzing lipid groups at C-4 sites of iridoid in geniposide to obtain geniposidic acid, then acetylating five hydroxyl groups at 2 ', 3', 4 ', 6' and 11 sites on sugar to obtain penta-acetyl geniposidic acid (2a), and finally reacting with RNH2 to obtain the penta-acetyl geniposide derivative. The geniposide derivative prepared by the invention has remarkable XOD inhibitory activity and kidney injury improvement activity, and can effectively reduce the accumulation of uric acid in the kidney. The inflammatory reaction is reduced, so that the level of inflammatory factors is reduced; renal fibrosis of a mouse with hyperuricemia can be reduced by inhibiting expression of an inflammatory factor TGF-beta.

Description

technical field [0001] The invention belongs to the technical field of preparation of new compounds, and in particular relates to an amide pentaacetylgeniposide derivative and a preparation method and application thereof. Background technique [0002] Hyperuricemia is a metabolic disease caused by the disorder of purine metabolism in the body. In recent years, the number of patients with hyperuricemia has been increasing, and it has become the second largest metabolic disease. Long-term hyperuricemia can lead to many complications, especially kidney inflammation, and in severe cases, renal fibrosis, which can seriously damage kidney function. Xanthine oxidase (XOD) plays an important role in uric acid metabolism in vivo and is a key enzyme regulating uric acid production. Therefore, most of the current uric acid-lowering drugs target XOD, such as allopurinol, febuxostat, etc. However, most of these XOD inhibitors have obvious toxic side effects, which can cause kidney dam...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07H17/04C07H1/00C07H1/06A61P19/06
CPCC07H17/04C07H1/00C07H1/06A61P19/06Y02P20/55
Inventor 刘超孙金月陈家树王目旋郭溆陈莹莹王青张梦启
Owner VEGETABLE RES INST OF SHANDONG ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com